Nestle’s health science division has acquired US-based Pamlab as part of the company’s startegy to expand its presence in medical nutrition.

Nestle said yesterday (26 February) that it has bought Pamlab for an undisclosed fee.

The Swiss food giant runs its health science division as a fully owned subsidiary and has spent the past year building its presence in the area of medical nutrition.

Pamlab produces a range of “medical food products for use under medical supervision in the nutritional management of patients with mild cognitive impairment, depression and diabetic peripheral neuropathy”, Nestle said.

One of its products, Metanx, helps to regulate metabolic processes associated with brain health in diabetes patients. It also makes Deplin, which is used to provide nutritional support for those taking antidepressants.

In 2012, Nestlé Health Science agreed to form a 50/50 joint venture named Nutrition Science Partners Ltd, to develop nutritional and medicinal products derived from plants to address gastrointestinal disorders. The transaction is still subject to regulatory approval.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData